“The opening of a new topical drug facility at our plant in the fourth quarter of 2021, which will double production capacity from 270 tons to 500 tons and will also lead to higher revenue in Romania and on the international markets,” is the main investment of the local pharmaceutical producer in 2021.
More than RON30 million will go towards new investments, RON10 million of which towards research and development investments.
The investment in the new topical drug facility stands at EUR20 million and was announced as early as 2018. The new facility will take up 2,500 square meters and make creams, ointments, gels and suppositories. Antibiotice is the national leader on the topical drug segment.
(English version by Loredana Fratila-Cristescu)